Evidence map›Paper›PMID 40167764›Full record

ArticleJournal of neurology2025

Natural history of adult-onset metachromatic leukodystrophy.

Daniele Mandia, Juliette Dufour, Silvia Fenu, Ettore Salsano, Chiara Benzoni, François Sellal, Jeremie Pariente, Nilgün Cengiz, Magali Pettazzoni, Thierry Levade and 13 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Daniele MandiaNeuro-Metabolism Unit, Reference Center for Metabolic and Lysosomal Neurological Diseases, Neurology Department, Hôpital Pitié-Salpêtrière, Paris, France.
Juliette DufourNeurology Department, Hôpital Pitié-Salpêtrière, Paris, France.
Silvia FenuUnit of Rare Neurological Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milan, Italy.
Ettore SalsanoUnit of Rare Neurological Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milan, Italy.
Chiara BenzoniUnit of Rare Neurological Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milan, Italy.
François SellalDépartement de Neurologie, Hôpitaux Civils de Colmar, 39, avenue de la Liberté, 68000, Colmar, France.
Jeremie ParienteNeurology, CHU Toulouse, Hôpital Purpan, Toulouse, France.
Nilgün CengizDepartment of Neurology, Faculty of Medicine, Ondokuz MayıS University, Samsun, Turkey.
Magali PettazzoniDepartment of Biochemistry and Molecular Biology, Hospices Civils de Lyon, Bron, France.
Thierry LevadeUnité Mixte de Recherche INSERM 1037, CNRS 5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.
Foudil LamariUF Biochimie des Maladies Neuro-Métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
Catherine CaillaudMetabolic Biochemistry Department, Necker-Enfants Malades Hospital, AP-HP, Université de Paris Cité, Paris, France.
Roberta La PianaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Mcgill University, 3801 rue University, Montreal, QC, H3A 2B4, Canada.
David BrassatInfinity, Université Toulouse, CNRS, INSERM, UPS, Toulouse, France.
Françoise Durand-DubiefDepartment of Neurology, Multiple Sclerosis, Myelin Disorders, and Neuro-Inflammation, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
Gérard BessonNeurology Department, Grenoble University Hospital, Grenoble, France.
Sylvie OdentService de Génétique Clinique, Centre de Référence "Anomalies du Développement et Syndromes Malformatifs" de l'Inter-Région Ouest, CHU Rennes, Univ Rennes, CNRS, INSERM, IGDR (Institut de Génétique Et Développement de Rennes) - UMR 6290, ERL U1305, Rennes, France.
David DevosMedical Pharmacology Department University of Lille & Parkinson's Disease Centre of Excellence, CHU Lille, INSERM U1172 - Degenerative & Vascular Cognitive Disorders, LilNCog, Lille Neuroscience & Cognition, LICEND, NS-Park Network, Lille, France.
Mélanie BarbayService de Neurologie CHU Amiens et Laboratoire de Neurosciences Fonctionnelles et Pathologies, Université de Picardie Jules Verne, Amiens, France.
Maria MakrygianniNeuro-Metabolism Unit, Reference Center for Metabolic and Lysosomal Neurological Diseases, Neurology Department, Hôpital Pitié-Salpêtrière, Paris, France.
Hojka Gregoric KumperscakDepartment for Child and Adolescent Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
Roseline FroissartDepartment of Biochemistry and Molecular Biology, Hospices Civils de Lyon, Bron, France.
Yann NadjarNeuro-Metabolism Unit, Reference Center for Metabolic and Lysosomal Neurological Diseases, Neurology Department, Hôpital Pitié-Salpêtrière, Paris, France. yann.nadjar@aphp.fr.ORCID http://orcid.org/0000-0003-1466-6957

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40167764
PMCPMC11961487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.